We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: ANTIDEPRESSANT LABELING SHOULD INCLUDE SUICIDE RISK
FDA: ANTIDEPRESSANT LABELING SHOULD INCLUDE SUICIDE RISK
March 26, 2004
Antidepressant drug manufacturers are being asked by the FDA to include warnings on product labeling recommending closer monitoring of adult and pediatric patients taking the drugs for worsening depression and suicidal thinking or behavior.